We found that ascorbate ameliorated hepatic steatosis induced by excess saturated fatty acid influx through changing cellular lipid profiles as well as improving insulin sensitivity which was related to inhibition of SOCS3. The gene discussed is SOCS3; the disease is fatty liver disease.